LEADER 01602oam  2200505Ia 450 
001 9910700310303321
005 20130109142230.0
035   $a(CKB)5470000002409888
035   $a(OCoLC)402364219
035   $a(EXLCZ)995470000002409888
100   $a20090504d2009      ba             0
101 0 $aeng
135   $aurmn|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aHybrid threats$b[electronic resource] $ereconceptualizing the evolving character of modern conflict /$fby Frank G. Hoffman
210  1$a[Washington, D.C.] :$cInstitute for National Strategic Studies, National Defense University,$d[2009]
215   $a1 online resource (8 pages) $ccolor illustrations
225 1 $aStrategic forum ;$vno.240
300   $aTitle from title screen (viewed on June 22, 2011).
300   $a"April 2009."
320   $aIncludes bibliographical references (page 8).
517   $aHybrid threats 
606   $aIrregular warfare
606   $aAsymmetric warfare
606   $aStrategy
606   $aMilitary doctrine
615  0$aIrregular warfare.
615  0$aAsymmetric warfare.
615  0$aStrategy.
615  0$aMilitary doctrine.
700   $aHoffman$b Frank G$01268945
712 02$aNational Defense University.$bInstitute for National Strategic Studies.
801  0$bDTICE
801  1$bDTICE
801  2$bOCLCQ
801  2$bGPO
801  2$bOCLCQ
801  2$bOCLCO
801  2$bGPO
906   $aBOOK
912   $a9910700310303321
996   $aHybrid threats$93482010
997   $aUNINA

LEADER 02097nas  2200625-  450 
001 9910502594703321
005 20230522213016.0
035   $a(OCoLC)1247472561
035   $a(CKB)4560000000001071
035   $a(CONSER)--2021201797
035   $a(DE-599)ZDB3098144-X
035   $a(EXLCZ)994560000000001071
100   $a20210426a20219999  ---         a
101 0 $aeng
135   $aur|||||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aCancer research communications
210  1$a[Philadelphia, Pennsylvania] :$cAmerican Association for Cancer Research,$d2021-
300   $aRefereed/Peer-reviewed
311 08$a2767-9764 
330   $aScope inculdes: Molecular and Cellular Biology -- Tumor Biology -- Immuno-oncology -- Therapeutic Research and Development -- Emerging Technologies and Data Science -- Precision Medicine and Biomarkers -- Clinical Research and Trials -- Epidemiology and Prevention -- Health Policy and Outcomes Research.
517 1 $aCRC
517 1 $aCancer res commun
531   $aCANCER RES COMMUN
531   $aBASIC ROMAN
531 0 $aCancer res. commun.
606   $aCancer$vPeriodicals
606   $aCancer$xTreatment$vPeriodicals
606   $aOncology
606   $aNeoplasms
606   $aMedical Oncology
606   $aCancer$vPériodiques
606   $aCancer$xTraitement$vPériodiques
606   $aCancérologie
606   $aCancer$xResearch$2fast$3(OCoLC)fst00845497
606   $aCancer$xTreatment$2fast$3(OCoLC)fst00845538
608   $aPeriodicals.$2fast
615  0$aCancer
615  0$aCancer$xTreatment
615  0$aOncology.
615 12$aNeoplasms.
615 22$aMedical Oncology.
615  6$aCancer
615  6$aCancer$xTraitement
615  6$aCancérologie.
615  7$aCancer$xResearch.
615  7$aCancer$xTreatment.
676   $a616
712 02$aAmerican Association for Cancer Research.
906   $aJOURNAL
912   $a9910502594703321
996   $aCancer research communications$91890303
997   $aUNINA